UNSPSC 41106104: Nuclease protection assays

UNSPSC 41106104 Nuclease protection assays (Commodity) covers specialized forensic and clinical laboratory reagents and consumables used for DNA analysis, extraction, quantification, and detection in criminal investigations, newborn screening, and pathogen identification. State and local governments buy these products primarily through the Texas Department of Public Safety, Texas Health and Human Services Commission, Illinois State Police, Mississippi Forensic Laboratory, and other state forensic and public health agencies. The scope spans Life Technologies, Promega, Qiagen, Abbott, and ANDE-manufactured products including RapidHIT cartridges and consumables for genetic analyzers, DNA extraction and quantification reagents, real-time PCR reagent kits, and ELISA test supplies for controlled-substance detection. Solicitations typically specify brand and SKU requirements with fixed quantities, impose cold-chain storage and shelf-life compliance, and require compatibility with particular analyzer platforms such as Applied Biosystems 3500 genetic analyzers. Contracts generally run one to four years with optional renewal periods and include firm, fixed pricing with FOB destination delivery.

Recent activity concentrates heavily in Texas, where the Department of Public Safety, Health and Human Services Commission, and Comptroller of Public Accounts have posted multiple IFB solicitations since May 2026. The Texas Comptroller posted IFB 304T-27-175A1.1 on September 23, 2026 (due October 20, 2026) for proprietary chemical laboratory equipment and supplies spanning 50 line items of DNA analysis and drug-screening consumables for statewide delivery to DPS and Parks and Wildlife; historical usage data drives quantities ranging from 8 to 5,000 units per item, and the contract runs through October 31, 2027 with three one-year renewal options. The Texas Department of Public Safety issued IFB 405-26R0017287 on July 7, 2026 (due July 22, 2026) for nine line items of RapidHIT consumables for the Crime Lab in Austin. The Texas Health and Human Services Commission posted IFB HHS0017640 on July 1, 2026 (due July 15, 2026) for DNA extraction reagents supporting newborn screening for SCID and SMA, with historical spend of $2.5 million over a three-month sample period and contract terms extending through August 31, 2031 with optional renewals. Illinois State Police Forensic Services Division and the Mississippi Forensic Laboratory have also solicited under this code, though with narrower scope or less detailed public documentation.